SCHEMBL4982963

SCHEMBL4982963

O=CN1CCCC2CCCC=C21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14831272 0.76
SCHEMBL10840451 0.71 DRD2 (0.32)
SCHEMBL770764 0.70 SMN1; SMN2 (0.33)
SCHEMBL9736803 0.70
SCHEMBL2824470 0.69 ALDH1A1 (0.33)
SCHEMBL770161 0.68 DPP4 (0.37)
SCHEMBL769747 0.68 ALDH1A1 (0.32)
SCHEMBL3264153 0.68 NOTUM (0.36)
SCHEMBL771484 0.67 LMNA (0.30)
SCHEMBL771465 0.67 LMNA (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7345058-B2 (1-Methyl-5-phenyl-1H-pyrazol-4-yl)-(trans-octahydro-isoquinolin-2-yl)methanone; 11 beta -hydroxysteroid dehydrogenase inhibitor; upregulation of phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (G6Pase); antidiabetic agent; type II diabetes mellitus and metabolic syndrome HOFFMANN-LA ROCHE INC. (US) 2008-03-18 US disclosed
US-20060223852-A1 Pyrazoles GILLESPIE PAUL 2006-10-05 US disclosed